Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeremiah Depta

Internal Medicine Milwaukee, WI Medical Doctor

NPI 1548453939 CMS profile 206685

9200 W Wisconsin Ave, Milwaukee, WI 53226

Open in the dashboard

General payments

$723,499

1,083 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,521,929 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jeremiah Depta of Milwaukee, WI is reported in the CMS Open Payments database as having received $723,499 across 1,083 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,521,929 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $111,150 118
2024 General $139,283 140
2023 General $163,882 182
2022 General $110,063 203
2021 General $75,258 149
2020 General $59,353 103
2019 General $64,509 188

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeremiah Depta
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Jeremiah Depta were reported at $111,150. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Jeremiah Depta Internal Medicine median Middle half National median
2019 $64,509 $159 $48–$570 $163
2020 $59,353 $119 $33–$402 $114
2021 $75,258 $135 $37–$521 $132
2022 $110,063 $141 $42–$496 $149
2023 $163,882 $149 $45–$519 $160
2024 $139,283 $154 $47–$537 $164
2025 $111,150 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $607,981 794 payments
  2. Boston Scientific Corporation $101,367 178 payments
  3. Medtronic, Inc. $8,183 18 payments
  4. Abbott Laboratories $5,064 69 payments
  5. W. L. Gore & Associates, Inc. $227 4 payments
  6. Shockwave Medical, Inc $186 1 payment
  7. Asahi Intecc USA, Inc. $122 1 payment
  8. Pfizer Inc. $75 5 payments
  9. Smith+Nephew, Inc. $59 2 payments
  10. Biosense Webster, Inc. $56 3 payments
  11. Other $180 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $495,003 141 payments
  2. Travel and Lodging $102,076 270 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $65,629 20 payments
  4. Honoraria $33,500 11 payments
  5. Food and Beverage $27,291 641 payments
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $441,668 321 payments
  2. Edwards SAPIEN 3 Transcatheter Heart Valve $107,015 158 payments
  3. WATCHMAN Access System $36,794 62 payments
  4. WATCHMAN FLX $16,760 12 payments
  5. General - Therapies $11,981 14 payments
  6. COREVALVE EVOLUT R $8,079 14 payments
  7. SAPIEN 3 Ultra RESILIA $7,276 82 payments
  8. WATCHMAN $5,705 6 payments
  9. PASCAL $5,205 5 payments
  10. GENERAL VASCULAR ACCESS $4,942 3 payments
  11. Other $28,192 311 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$100,666

Medicare's payments for the services billed

Medicare patients

160

Average age 78

Services billed

479

79 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 66%
Atrial fibrillation 58%
Arthritis 53%
Diabetes 38%
Chronic kidney disease 38%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,083 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record